(Total Views: 302)
Posted On: 09/24/2018 8:37:30 AM
Post# of 72443
Excellent article showing why B-OM the leader of the pack. I highlighted a statement from the article below as I was unaware Brilacidin was working in the cancer arena as well as antibiotic/anti inflammatory.
“In aggregate, the data from the Brilacidin Phase 2 study was impressive and we will consider expanding the drug to other cancer indications in the future,” said Leo Ehrlich,
“In aggregate, the data from the Brilacidin Phase 2 study was impressive and we will consider expanding the drug to other cancer indications in the future,” said Leo Ehrlich,
(2)
(0)Scroll down for more posts ▼
